Medtronic Inc (NYSE:MDT) – Medtronic Applauds AACE/ACE on Their Updated Insulin Pump Therapy Consensus Statement

[Thomson Reuters ONE] – MINNEAPOLIS – May 19, 2014 – Medtronic, Inc. (NYSE:MDT) applauds the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) on their updated consensus … . . . → Read More: Medtronic Inc (NYSE:MDT) – Medtronic Applauds AACE/ACE on Their Updated Insulin Pump Therapy Consensus Statement Similar Articles: Market Update: Medtronic Inc (NYSE:MDT) – Medtronic Names Hooman Hakami Executive Vice President and Group President of the Medtronic Diabetes Group Company Update (NYSE:MDT): Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe Company Update: Medtronic Inc (NYSE:MDT) – Medtronic Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes